Structure-based 3D-Pharmacophore modeling to discover novel interleukin 6 inhibitors: An in silico screening, molecular dynamics simulations and binding free …

QH Tran, QT Nguyen, NQH Vo, TT Mai, TTN Tran… - PLoS …, 2022 - journals.plos.org
Interleukin 6 (IL-6) is a cytokine with various biological functions in immune regulation,
hematopoiesis, and inflammation. Elevated IL-6 levels have been identified in several …

[HTML][HTML] Identification of triterpenoid saponin inhibitors of interleukin (IL)-33 signaling from the roots of Astragalus membranaceus

LB Vinh, YK Han, SY Park, YJ Kim, NV Phong… - Journal of Functional …, 2023 - Elsevier
Abstract Interleukin-33 (IL-33) is a cytokine produced by epithelial cells that plays a key role
in immune-mediated diseases, such as asthma, atopic dermatitis, and rheumatoid arthritis …

In silico design, synthesis, and biological evaluation of anticancer arylsulfonamide endowed with anti-telomerase activity

G Culletta, M Allegra, AM Almerico, I Restivo… - Pharmaceuticals, 2022 - mdpi.com
Telomerase, a reverse transcriptase enzyme involved in DNA synthesis, has a tangible role
in tumor progression. Several studies have evidenced telomerase as a promising target for …

Discovery of benzothiazole-based thiazolidinones as potential anti-inflammatory agents: Anti-inflammatory activity, soybean lipoxygenase inhibition effect and …

M Haroun, A Petrou, C Tratrat, K Kositsi… - SAR and QSAR in …, 2022 - Taylor & Francis
Despite the greatest achievement in the development of anti-inflammatory agents in the last
two decades, the current clinical drugs suffer from a variety of complications in community …

Toward Unveiling Putative Binding Sites of Interleukin-33: Insights from Mixed-Solvent Molecular Dynamics Simulations of the Interleukin-1 Family

TT Mai, TP Lam, LHD Pham, KH Nguyen… - The Journal of …, 2024 - ACS Publications
The interleukin (IL)-1 family is a major proinflammatory cytokine family, ranging from the well-
studied IL-1s to the most recently discovered IL-33. As a new focus, IL-33 has attracted …

Discovery of small molecular inhibitors for interleukin-33/ST2 protein–protein interaction: A virtual screening, molecular dynamics simulations and binding free energy …

TT Mai, PG Nguyen, MT Le, TD Tran, PNH Huynh… - Molecular Diversity, 2022 - Springer
The interleukin-1 receptor like ST2 has emerged as a potential drug discovery target since it
was identified as the receptor of the novel cytokine IL-33, which is involved in many …

Discovery of AcrAB-TolC pump inhibitors: Virtual screening and molecular dynamics simulation approach

TV Phan, VTV Nguyen, CHH Nguyen… - Journal of …, 2023 - Taylor & Francis
AcrAB-TolC tripartite efflux pump, which belongs to the RND superfamily, is a main multi-
drug efflux system of Escherichia coli (E. coli) because of the broad resistance on various …

Computational assessment and in vitro test of phytochemicals of Usnea aciculifera as potential inhibitors of Escherichia coli efflux pump AcrB

TV Phan, LT Tuong, VTV Nguyen, CVT Vo… - Journal of …, 2025 - Taylor & Francis
Lichens produce secondary metabolites that have many pharmaceutical activities such as
antimicrobial, antioxidant, antiviral, anticancer, antigenotoxic, anti-inflammatory, analgesic …

Identification of potential interleukin-8 inhibitors acting on the interactive site between chemokine and CXCR2 receptor: A computational approach

TTN Tran, QH Tran, QT Nguyen, MT Le, DTT Trinh… - Plos one, 2022 - journals.plos.org
Interactions between interleukin (IL)-8 and its receptors, CXCR1, and CXCR2, serve crucial
roles in inflammatory conditions and various types of cancers. Inhibition of this signaling …

In silico approach to identify novel allosteric intracellular antagonist for blocking the interleukin-8/CXCR2 receptor signaling pathway

TTN Tran, QH Tran, CQ Duong… - Journal of …, 2023 - Taylor & Francis
The role of interleukin-8 (IL-8) and its receptor CXCR2 in inflammatory responses and tumor
development and progression has been well documented. Our study aims to discover novel …